nimodipine has been researched along with Central Nervous System Lyme Disease in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobi, C | 1 |
| Schwark, C | 1 |
| Kress, B | 1 |
| Hug, A | 1 |
| Storch-Hagenlocher, B | 1 |
| Schwaninger, M | 1 |
1 other study available for nimodipine and Central Nervous System Lyme Disease
| Article | Year |
|---|---|
Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Cefuroxime; Cerebral Angiography; Female; Humans; | 2006 |